5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.

5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.

BACKGROUND and AIMS: This study was performed to quantify the risk of renal disease in patients using aminosalicylates (5-ASA). METHODS: Data from the United Kingdom General Practice Research Database were used to estimate the incidence of renal disease in adult patients with inflammatory bowel dis...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Van Staa, T, Travis, S, Leufkens, H, Logan, R
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2004

Παρόμοια τεκμήρια

Renal Effects of Long-Term Treatment with 5-Aminosalicylic Acid
ανά: Harshna Patel, κ.ά.
Έκδοση: (2009-01-01)

Sonoelectrochemically enhanced determination of 5-aminosalicylic acid.
ανά: Beckett, E, κ.ά.
Έκδοση: (2001)

Therapy of Inflammatory Bowel Disease using 5-Aminosalicylic Acid, 4-Aminosalicylic Acid and Olsalazine Retention Enemas: Review of Clinical Trials
ανά: M. Campieri, κ.ά.
Έκδοση: (1989-01-01)

Mechanism of action of 5-aminosalicylic acid and its derivatives.
ανά: Ireland, A, κ.ά.
Έκδοση: (1990)

Electroanalytical Overview: The Sensing of Mesalamine (5-Aminosalicylic Acid)
ανά: Robert D. Crapnell, κ.ά.
Έκδοση: (2023-12-01)

Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease
ανά: Andrew W Kirkpatrick, κ.ά.
Έκδοση: (1999-01-01)

Pharmacokinetics of 5-Aminosalicylic Acid Enteral Suspension in Crohn's Disease Patients and Normal Volunteers
ανά: CN Williams, κ.ά.
Έκδοση: (1990-01-01)

Aminosalicylates in inflammatory bowel disease
ανά: Vojislav N. Perisic
Έκδοση: (2013-10-01)

Controlled Release of 5-Aminosalicylic Acid (5-ASA) from New Biodegradable Polyurethanes
ανά: El-Refaie Kenawy, κ.ά.
Έκδοση: (2010-03-01)

Does a fracture at one site predict later fractures at other sites? A British cohort study.
ανά: van Staa, T, κ.ά.
Έκδοση: (2002)

Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells.
ανά: Ireland, A, κ.ά.
Έκδοση: (1990)

Efficacy of 5-Aminosalicylic Acid Enemas in the Treatment of Distal Ulcerative Colitis
ανά: MG Robinson, κ.ά.
Έκδοση: (1990-01-01)

Flavonoids and 5-Aminosalicylic Acid Inhibit the Formation of Neutrophil Extracellular Traps
ανά: Tina Kirchner, κ.ά.
Έκδοση: (2013-01-01)

Perimyocarditis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid
ανά: Hye Young Lee, κ.ά.
Έκδοση: (2024-05-01)

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
ανά: Long He, κ.ά.
Έκδοση: (2021-05-01)

5-Aminosalicylic Acid Chemoprevention in Inflammatory Bowel Diseases: Is It Necessary in the Age of Biologics and Small Molecules?
ανά: Hans Herfarth, κ.ά.
Έκδοση: (2021-09-01)

Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid
ανά: Ashok K. Batta, κ.ά.
Έκδοση: (1998-08-01)

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.
ανά: van Staa, T, κ.ά.
Έκδοση: (2002)

Studies on the acetylating capacity of human colonic epithelial cells for 5-aminosalicylic acid.
ανά: Ireland, A, κ.ά.
Έκδοση: (1988)

5-Aminosalicylic Acid Enemas in the Maintenance of Remission in Distal Ulcerative Colitis and Proctitis
ανά: Lloyd R Sutherland, κ.ά.
Έκδοση: (1987-01-01)

Unveiling the Unexplored Multifactorial Potential of 5-Aminosalicylic Acid in Diabetic Wound Therapy
ανά: Bharat Kumar Reddy Sanapalli, κ.ά.
Έκδοση: (2024-08-01)

5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis
ανά: Jihee Kim, κ.ά.
Έκδοση: (2024-02-01)

Effect of intra-abdominally administered mesalazine (5-aminosalicylic acid) in experimental peritonitis
ανά: Aziz Şener, κ.ά.
Έκδοση: (2018-09-01)

USE OF 5-AMINOSALICYLIC ACID FOR TREATMENT OF ULCERATIVE COLITIS IN DIFFERENT DOSAGE MODES
ανά: M. V. Shapina, κ.ά.
Έκδοση: (2017-11-01)

5-Aminosalicylic Acid-induced Myocarditis in a Patient with Atypical Ulcerative Colitis
ανά: Hyo Yeop Song, κ.ά.
Έκδοση: (2022-01-01)

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
ανά: Yan Yan, κ.ά.
Έκδοση: (2019-12-01)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
ανά: Jun Xu, κ.ά.
Έκδοση: (2018-06-01)

Epidemiology of fractures in England and Wales.
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

The epidemiology of fractures in England and Wales
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
ανά: Ajit Sood, κ.ά.
Έκδοση: (2020-10-01)

Five-Aminosalicylic Acid: An Update for the Reappraisal of an Old Drug
ανά: Cristiana Perrotta, κ.ά.
Έκδοση: (2015-01-01)

Effect of High Dose Aminosalicylic Acid on Gastroduodenal Mucosa
ανά: DJ Leddin, κ.ά.
Έκδοση: (1993-01-01)

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
ανά: Shinta Mizuno, κ.ά.
Έκδοση: (2020-01-01)

5-Aminosalicylic acid inhibits the impaired epithelial barrier function induced by gamma interferon.
ανά: Paolo, D, κ.ά.
Έκδοση: (1996)

Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance
ανά: Hiroshi Matsumoto, κ.ά.
Έκδοση: (2024-09-01)

Prevention of Relapse in Ulcerative Colitis Using Oral or Topical 5-Aminosalicylic Acid Therapy
ανά: Lloyd R Sutherland
Έκδοση: (1993-01-01)

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
ανά: Soo-Kyung Park, κ.ά.
Έκδοση: (2022-09-01)

Preparation and in-vitro characterization of 5-aminosalicylic acid loaded hydrogels for colon specific delivery
ανά: Muhammad Suhail, κ.ά.
Έκδοση: (2022-11-01)

Synthesis, characterization and radical scavenging activity of aromatic amine conjugates of 5-aminosalicylic acid
ανά: K. Harveer,, κ.ά.
Έκδοση: (2014-09-01)

Preparation and evaluation of magnetic microspheres of mesalamine (5-aminosalicylic acid) for colon drug delivery
ανά: Satinder Kakar, κ.ά.
Έκδοση: (2013-01-01)